World Health Organization Raises Concern Over Severe Scarcity of Obesity Medications
Fewer than one in 10 patients eligible to benefit from weight-loss injections including Wegovy can access them, caution the World Health Organization as it releases its initial advice on the therapies.
With more than one billion individuals worldwide now living with obesity, it is calling for more widespread and fairer availability to this class of drugs.
Based on forecasts, over two billion are projected to be living with obesity by 2030 without intervention.
"The latest guidance recognises that obesity is a long-term condition that can be managed with comprehensive and lifelong treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are major barriers to widespread access to the treatments that can help people shift substantial body mass, says the agency.
Skinny Jab Supply Crisis
Even in the present best projected case, the production of GLP-1 therapies could only cover about 100 million people – fewer than 10% of eligible patients, per the health organization.
The recommendation encourages nations and manufacturers to expand availability, through strategies such as voluntary licensing.
Exclusive production rights on the active ingredient – the core component of a leading brand – is set to lapse in several nations in 2026.
The Way Weight-Loss Jabs Function
The injections replicate a body's own hormone to slow digestion, reduce hunger and increase the sense of being full so users consume fewer calories.
Patients usually see weight reduction after several weeks of commencing the once-weekly jabs.
Evidence suggests people may put most of the weight back on within a year of stopping the treatment, as their usual appetite come back.
Being overweight or obese increases your chance for developing diseases, such as type 2 diabetes, heart disease, stroke, and certain cancers.
Obesity concerns individuals in all nations and was responsible for 3.7 million fatalities worldwide in 2024, per the health agency.
